We teamed up with Omada Health to quantify how much of patient care can be delivered virtually vs. in person
But it’s also one of the hardest - here’s why.
With HTN, we surveyed 150 investors, founders & operators on the 'New Normal' - here's the results
A deep dive on the latest trends in federal lobbying activity and legislative reform in the US
We compiled a short-list so you don't have to
We compiled a list so you don't have to
Top talent may have different priorities than you might expect...
Why we remain bullish on services, even as the market has shifted to favor software
We broke it down so you don't have to
Don't worry, you can hold us all accountable next year...
A call to action for health tech builders
Meghan Fitzgerald's investment thesis is grounded in her experiences across pharmacy, pharma and health systems - as well as countless hours spent in the ICU.
